A study published in Clinical Lung Cancer finds that 93% of oncologists adjust their treatment recommendations with the help of PROphetNSCLC, a test developed by Israel’s OncoHost (see here previously).

https://www.ourcrowd.com/startup-news/clinical-lung-cancer-publishes-study-93-of-oncologists-adjust-treatment-recommendations-with-oncohosts-prophetnsclc-test

https://www.clinical-lung-cancer.com/article/S1525-7304(24)00138-4/fulltext